Detalles de la búsqueda
1.
Treatment intensification following glucagon-like peptide-1 receptor agonist in type 2 diabetes: Comparative effectiveness analyses between free vs. fixed combination of GLP-1 RA and basal insulin. RESTORE-G real-world study.
Nutr Metab Cardiovasc Dis
; 2024 Mar 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38693036
2.
Treatment intensification following glucagon-like peptide-1 receptor agonist treatment in type 2 diabetes: The RESTORE-G real-world study.
Nutr Metab Cardiovasc Dis
; 33(11): 2294-2305, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37679243
3.
Comparative effectiveness of Glargine 300 U/mL vs. Degludec 100 U/mL in patients with type 2 diabetes switching from 1° generation basal insulins.
Nutr Metab Cardiovasc Dis
; 32(9): 2255-2263, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35961826
4.
Clinical profiles and quality of care of subjects with type 2 diabetes according to their cardiovascular risk: an observational, retrospective study.
Cardiovasc Diabetol
; 20(1): 59, 2021 03 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33676499
5.
Impact of severe and symptomatic hypoglycemia on quality of life and fear of hypoglycemia in type 1 and type 2 diabetes. Results of the Hypos-1 observational study.
Nutr Metab Cardiovasc Dis
; 29(7): 736-743, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31153746
6.
Liraglutide and cardiovascular outcomes in a real world type 2 diabetes cohort.
Pharmacol Res
; 137: 270-279, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30213563
7.
Corrigendum to Comparative effectiveness of Glargine 300 U/mL vs. Degludec 100 U/mL in patients with type 2 diabetes switching from 1° generation basal insulins > Nutr Metab Cardiovasc Dis. 2022 Sep;32(9):2255-2263.
Nutr Metab Cardiovasc Dis
; 33(4): 920-921, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36948942
8.
Occurrence over time and regression of nonalcoholic fatty liver disease in type 2 diabetes.
Diabetes Metab Res Rev
; 33(4)2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28032449
9.
Variability in HbA1c, blood pressure, lipid parameters and serum uric acid, and risk of development of chronic kidney disease in type 2 diabetes.
Diabetes Obes Metab
; 19(11): 1570-1578, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28432733
10.
The complex interplay between clinical and person-centered diabetes outcomes in the two genders.
Health Qual Life Outcomes
; 15(1): 41, 2017 Feb 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-28222781
11.
The long-term effects of stillbirth on women with and without gestational diabetes: a population-based cohort study.
Diabetologia
; 58(1): 67-74, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25312813
12.
Achievement of therapeutic targets in patients with diabetes and chronic kidney disease: insights from the Associazione Medici Diabetologi Annals initiative.
Nephrol Dial Transplant
; 30(9): 1526-33, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25883195
13.
Kidney dysfunction and related cardiovascular risk factors among patients with type 2 diabetes.
Nephrol Dial Transplant
; 29(3): 657-62, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24398892
14.
Continuous improvement of quality of care in pediatric diabetes: the ISPED CARD clinical registry.
Acta Diabetol
; 61(5): 599-607, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38332378
15.
Effectiveness of switching from first-generation basal insulin to Glargine 300 U/mL in children and adolescents with type 1 diabetes: results from the ISPED CARD database.
Acta Diabetol
; 2024 May 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38789610
16.
Effectiveness, Safety, and Appropriateness in the Use of the Fixed-Ratio Combination of Insulin Glargine and Lixisenatide in Type 2 Diabetes: The ENSURE Retrospective Real-World Study.
Diabetes Ther
; 14(1): 77-92, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36376644
17.
The Burden of Obesity in Type 1 Diabetic Subjects: A Sex-specific Analysis From the AMD Annals Initiative.
J Clin Endocrinol Metab
; 108(11): e1224-e1235, 2023 10 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37247381
18.
Comparative effectiveness and safety of glargine 300 U/mL versus degludec 100 U/mL in insulin-naïve patients with type 2 diabetes. A multicenter retrospective real-world study (RESTORE-2 NAIVE STUDY).
Acta Diabetol
; 59(10): 1317-1330, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35864262
19.
Prediction of complications of type 2 Diabetes: A Machine learning approach.
Diabetes Res Clin Pract
; 190: 110013, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35870573
20.
Effectiveness and Tolerability of Once-Weekly GLP-1 Receptor Agonists in Clinical Practice: A Focus on Switching Between Once-Weekly Molecules in Type 2 Diabetes.
Front Endocrinol (Lausanne)
; 13: 892702, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35909534